Cancer Research Institute (CRI) shared a post on LinkedIn:
“Thanks to immunotherapy, cancer patients like Jenney, who was diagnosed with stage 4 metastatic melanoma, have a chance to not just survive, but thrive. After only five months of treatment, her oncologist shared that she had no evidence of disease.
‘Before immunoncology, we weren’t really able to say the word ‘cure’ for these patients who were suffering from Stage IV metastatic disease, and now we can,’ CRI’s CEO Alicia Zhou, PhD describes. “It’s really, truly transformational for these patients.”
Hear more of Jenney’s inspiring immunotherapy story, from CBS News.”
Other articles from Cancer Research Institute on OncoDaily.